DOCSLIB.ORG

Therapeutics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

第四届中美纳米医学与纳米生物技术年会 The 4th Annual Meeting of Chinese American Society of Nanomedicine and Nanobiotechnology 会议手册 Conference Handbook 19th - 22nd August 2019 | Hangzhou, China Welcome Message Dear Friends and Colleagues, On behalf of the organizing committee and Zhejiang University, the hosting institution, we welcome you to Hangzhou for the 4th International Symposium for Chinese American Society of Nanomedicine and Nanobiotechnology (CASNN) during August 20-22, 2019. CASNN was initially proposed by a group of active Chinese scholars in USA and China as an informal WeChat group and formally established in 2016. Its primary objective is to promote international communication, primarily between USA and China, for the advancement of nanomedicine and nanobiotechnology and to foster inclusive and collaborative interactions among researchers and institutions working in those areas. This annual symposium series has been successfully held in Nanjing (2018), Suzhou (2017) and Beijing (2016). The 4th CASNN meeting committee has invited and assembled a strong list of international speakers from academia, industry, and government agencies. This list includes 130 prominent scientists and leading experts with diverse backgrounds in Engineering, Chemistry, Medicine, and Pharmacy. In addition, there are more than 300 poster presentations contributed by graduate students, postdoctoral and medical researchers. In the past twenty years, nanomedicine and bionanotechnology have experienced remarkable advances enabled by scientific discoveries and breakthroughs. We felt that it is imperative to reiterate the significance of fundamental and transformative concepts. Thus, we place the conference theme under “Transform Nanomedicine with Breakthrough Thinking”. The meeting also includes discussion forums for Emerging Leaders and Rising Stars, aiming to stimulate provocative discussions on the most critical issues in nanomedicine and nanobiotechnology. We thank the staff members, volunteers, and session chairs for helping us build this exciting program. The organizing and scientific committees will make every effort to make sure your participation is scientifically rewarding, and your trip to Hangzhou (the Paradise on Earth) pleasurable and relaxing. Yours Sincerely, Co-Chair: Youqing Shen Co-Chair: Honggang Cui Ph.D., Professor Ph.D., Associate Professor Center for BioNanoEngineering Dept. of Chemical and Biomolecular College of Chemical and Biological Engineering Engineering Institute for NanoBioTechnology Zhejiang University, 38 Zheda ST The Johns Hopkins University Hangzhou, China 310027 3400 N. Charles Street, Baltimore, MD 21218 Phone/Fax: 86-571-87953993 Phone: 001(410) 516-6878 E-mail: [email protected] E-mail: [email protected]; http://orcid.org/0000-0003-1837-7976 http://www.jhu.edu/cui 1 欢迎辞 第四届中美纳米医学与纳米生物技术年会由中美纳米药物与纳米生物技术学会（CASNN） 主办，前三届的会议（2016，北京；2017，苏州；2018，南京）取得了巨大的成功。 第四届大会会议的主题是“推动纳米医学发展的变革性思维——Transform Nanomedicine with Breakthrough Thinking”，旨在共同探讨纳米药物/纳米医学的发展愿 景、面临的挑战及解决策略，推动纳米医学与纳米生物技术相关产业的蓬勃发展, 促进中美 纳米医学与纳米生物技术领域项目和技术的交流、合作。 会议议题 ※变革性纳米药物论坛 ※先进纳米药物/制剂与功能辅料 ※肿瘤免疫治疗的纳米药物/制剂 ※用于疾病检测的生物传感器和生物芯片 ※纳米药物的个性化治疗和临床转化 会议已邀请来自中国、美国、加拿大、日本、韩国、新加坡等国家和地区的院士和专家 及国内知名药企人员，预计参会人数约 500 人。会议将于 2019 年 8 月 19 号报到，20-22 日 在杭州举行。 我们热忱欢迎大家出席此次学术盛会！期待在各位同行的支持下，本次会议将取得圆满 成功！ 大会主席 申有青 教授 崔宏刚 教授 浙江大学 约翰霍普金斯大学 申有青 教授 崔宏刚 教授 浙江大学 约翰霍普金斯大学 2 主办单位 中美纳米医学与纳米生物技术学会（CASNN） 承办单位 浙江大学 杭州市萧山区人民政府 协办单位 萧山区委人才办 浙江大学生物质化工教育部重点实室 萧山区投资促进局 冷泉港生物科技股份有限公司 萧山科技城管理局 浙江省药学会生物制药专业委员会 化学工程国家重点实验室（浙江大学） 浙江湘湖影视文化有限公司 浙江理工大学 浙江原始资本管理有限公司 学术委员会 主任： 陈小元 美国国立卫生研究院 程建军 伊利诺伊大学 蒋兴宇 中国国家纳米科学中心 成员: 蔡林涛 中科院深圳先进技术研究院 李 春 MD 安德森癌症中心 蔡伟波 威斯康星大学麦迪逊分校 刘 滨 新加坡国立大学 陈小元 美国国立卫生研究院 刘 庄 苏州大学 程建军 伊利诺伊大学 申有青 浙江大学 崔宏刚 约翰霍普金斯大学 王 均 华南理工大学 高明远 中国科学院化学研究所 王强斌 中科院苏州纳米所 高虓虎 华盛顿大学 张 灿 中国药科大学 宫绍琴 威斯康星大学麦迪逊分校 张良方 加州大学圣地亚哥分校 顾 臻 加州大学洛杉矶分校 3 Opening and Plenary Conference Hall Opening Ceremony •Welcome Speech from Lizhong Wang, Vice President of Zhejiang University Chairs: •Welcome Speech from Xiaoshan District 08:30-09:00 •Introduction of Xiaoshan Investment Policy Youqing Shen •Introduction of Xiaoshan Science and Technology Polis •Unveiling of CASNN-Xiaoshan Center for Technology Translations Prof. Yuliang Zhao 09:00-9:30 National Center for Nanoscience and Technology CASNN Honggang Mechanisms of Nanotoxicity and Nanomedicine Cui Prof. Shuming Nie Award Youqing Lectures University of Illinois at Urbana-Champaign 9:30-10:00 Nanotechnology: from Single Molecule Raman Spectroscopy to Shen Image-Guided Cancer Surgery Opening Prof. Nicholas A. Peppas 20 Morning 20 Morning 10:00-10:40 Plenary University of Texas at Austin Yuliang Zhao Lecture Molecular Recognition at the Nanoscale Level 10:40-11:00 Coffee Break & Photographing August Prof. Paul S. Weiss University of California, Los Angeles 11:00-11:30 Adding the Chemical Dimension to Lithography at All Scales: Enabling Cellular Therapies & Other Adventures in Biology and Medicine Jianjun 11:30-12:00 Plenary Prof. Justin Hanes Cheng Lectures Johns Hopkins University Sarah Gong Nanomedicine: From Concept to Success in the Clinic 12:00-12:30 Prof. Kinam Park Purdue University PLGA Formulations: Understanding the Complexity of the PLGA Assay Lunch Prof. He Tian Chairs: 13:30-14:00 East China University of Science & Technology Dynamic Molecular Fluorescent Probes with Assembling Can Zhang Prof. Xi Zhang 14:00-14:30 Jilin University Xingyu Jiang Supramolecular Phototherapy Prof. Leaf Huang University of North Carolina at Chapel Hill 14:30-15:00 Xiaohu Gao Nanoparticles Targeting Tumor Microenvironment for Immunotherapy Plenary Dr. Pep Pàmies 15:00-15:30 Lectures Editor-in-Chief, Nature Biomedical Engineering Biomedical Engineering for Improving Human Health Dr. Fernanda Ogochi Prof. Kinam Park, EIC of JCR August 20 Afternoon 15:30-16:00 Executive Publisher,Elsevier Youqing Shen How to Get Published in High Impact Journals, Perspectives of the Editor and the Publisher Dr. Fuyao Zhang Shanghai Selection Bioscience Ltd. Co. 16:00-16:30 Enabling Platform for Transforming and Developing Nanomedicines 16:30-16:40 Coffee Break Session I: New Frontiers Session II: Therapeutics I Session III: Therapeutics II (Conference Hall A) (Conference Hall B) (Conference Room) Chairs: Xinyuan Zhu Chairs: Yi Hong Chairs: Yezi You Xintao Shuai Yong Wang Yongming Chen Xiongbin Lu Jie Zheng Qiang Zhang Indiana University University of Texas at Dallas Peking University Precision Medicine for Treating Triple 16:40-17:00 Renal Clearable Nanomedicines: Cellular Trafficking and Bioresponse of Negative Breast Cancer with From Fundamentals to Applications Nanomedicines Chromosome 17P Loss Kanyi Pu Yongzhuo Huang Nanyang Technological University Ling Peng Shanghai Instit. of Materia Medica, CAS Aix-Marseille University Molecular Optical Reporters for Targeting Tumor-Associated 17:00-17:20 Self-Assembling Supramolecular Ultrasensitive Afterglow Imaging Macrophage and Metablism as “Two- Dendrimers for Biomedical Applications and Early Diagnosis birds-One-stone" Therapeutic Strategy Ke Zhang Yongming Chen Northeastern University Yong Wang Sun Yat-Sen University Penn State University Making Oligonucleotides Better Molecular Bottlebrush as an 17:20-17:40 In Situ Nanomanufacturing on the Surface Biopharmaceuticals with Brush Unimolecular Vehicle for of Live Cells Polymers Nanomedicine August 20 Afternoon Yezi You Bing Xu Yi Hong Univ. of Science & Technology of China Brandeis University University of Texas at Arlington High Gene-Transfection Efficacy Using 17:40-18:00 Enzyme-Instructed Self-Assembly of Biodegradable Nanoparticles Enhancing Phenylboronate Micelles with Highly Peptide Nanofibers Bioadhesive Strength Selective Membrane Destruction 18:00-19:00 Dinner (Grand New Century Hotel) Poster Exhibition 19:00-21:30 Poster Award Selection Session I: New Frontiers Session II: Immunotherapy Session III: Diagnostics (Conference Hall A) (Conference Hall B) (Conference Room) Chairs: Chunying Chen Chairs: Xun Sun Chairs: Zhimou Yang Minglin Ma Hao Cheng Zhihong Nie Baran D. Sumer Gang Zheng Guanghui Ma UT Southwestern Medical Center University of Toronto & Princess Institute of Process Engineering, CAS Margaret Cancer Centre Targeting Acidosis in Cancer: A New 08:00-08:20 Bridging Systemic and Gastrointestinal Strategy Using a pH Transistor Nanoprobe Multifunctionality in Clinical Immune Responses for Enhanced Nanomedicine: Less is More? for Fluorescence-Guided Surgery in Vaccinations Humans Liqin Xiong Zhen Gu Yaping Li Shanghai Jiao Tong University University of California, Los Angeles Shanghai Institute of Materia Medica, CAS Multi-Functional Polymer Dots for 08:20-08:40 Glucose-Responsive Insulin and Enhanced Antitumor Activity of Icb Imaging of the Lymphatics, Adipose, and Delivery Devices Immunotherapy with in Situ Nanovaccines Nerves in Living Mice/Rats Minglin Ma Cornell University Hao Cheng Zhihong Nie Drexel University Fudan University 08:40-09:00 Toroidal Microgels and Their Applications for Type 1 Diabetes Cell Nanomaterials for Inducing Antigen- Engineering of Hybrid Nanovesicles for Replacement Therapies Specific Immune Tolerance Cancer Theranostics 21 Morning Chunying Chen National Center for Nanoscience and Xun Sun Zhimou Yang Sichuan University Nankai University 09:00-09:20 Technology Roles of the Protein Corona in Lymph Node Targeting for Improved Enzyme Instructed Peptide Folding, Self- Potency of Cancer Vaccine Assembly and Bioactivity Nanomedicine August Yucai Wang Changyou Zhan Qigang Wang Univ. of Science & Technology of China Fudan University Tongji University 09:20-09:35 Bio-Interfaces
Recommended publications
  • V11 HCM Brochure 06 01 21

    V11 HCM Brochure 06 01 21

    K J Somaiya Institute of Management (A Constituent Institute of Somaiya Vidyavihar University) Presents The 1st International Healthcare Management Conference 2021 On Future of Healthcare Post COVID-19 (Online mode) Phase I: 9th January, 2021 A) Keynote Address B) Panel Discussion C) Samavesh – Healthcare Management Case Study Competition Phase II: 27th March, 2021 International Conference and Research Paper Presentation Scientific Knowledge Partners Somaiya Vidyavihar University A new milestone in a glorious ongoing journey A new milestone in a glorious ongoing journey established in 2019, Somaiya Vidyavihar University, Mumbai, is a self-financed autonomous university recognised by the University Grants Commission (UGC). Somaiya Vidyavihar, with over six decades of rich experience in building and managing educational institutes of great repute, is the sponsoring body. Operational from 26th August 2019, Somaiya Vidyavihar University is a place where you can explore new possibilities, pursue your passion and above all, find yourself. Somaiya Vidyavihar University is located in the heart of Mumbai and boasts of a sprawling green campus. The university is equipped with excellent educational, recreational, community, health, and sports facilities. Somaiya Vidyavihar offers students the flexibility to simultaneously earn degrees and certifications in multiple disciplines offered by our constituent colleges. K J Somaiya Institute of Management K J Somaiya Institute of Management was established in 1981 as a part of Somaiya Vidyavihar (now affiliated to the Somaiya Vidyavihar University since August 2019) with the objective of providing state of the art education in management and allied areas. The institute is consistently ranked among the Top 25 management institutes and Top 10 private sector B-schools in India.
  • Kathryn A. Whitehead, Ph.D

    Kathryn A. Whitehead, Ph.D

    Kathryn A. Whitehead, Ph.D. Associate Professor Departments of Chemical Engineering and Biomedical Engineering Carnegie Mellon University 5000 Forbes Ave., DH A205 Pittsburgh, PA 15213 Office: (412) 268-9836 Fax: (412) 268-7139 Email: [email protected] Website: http://whitehead.cheme.cmu.edu EDUCATION University of California, Santa Barbara, Santa Barbara, CA December 2007 Doctor of Philosophy, Department of Chemical Engineering Advisor: Professor Samir Mitragotri University of Delaware, Newark, DE May 2002 Honors Bachelor of Chemical Engineering, Degree with Distinction, Magna Cum Laude Minor in Mathematics PROFESSIONAL POSITIONS Carnegie Mellon University, Associate Professor Department of Chemical Engineering, 2019 – present Department of Biomedical Engineering (courtesy), 2019 – present Carnegie Mellon University, Assistant Professor Department of Chemical Engineering, 2012 – 2019 Department of Biomedical Engineering (courtesy), 2013 – 2019 Massachusetts Institute of Technology, Postdoctoral Fellow David H. Koch Institute for Integrative Cancer Research, 2008 - 2012 Advisors: Professors Robert Langer & Daniel Anderson HONORS AND AWARDS Curtis W. McGraw Research Award (2019) Dean’s Early Career Fellowship (2019) George Tallman Ladd Research Award (2018) NIH Director’s New Innovator Award (2018) DARPA Director’s Fellowship (2018) Selected Delegate, Academy of Achievement International Summit (2017) Carnegie Science Center Emerging Female Faculty Award (2017) DARPA Young Faculty Award (2016) Cellular and Biomolecular Engineering Young Innovator
  • Samir Mitragotri, Ph.D

    Samir Mitragotri, Ph.D

    Samir Mitragotri, Ph.D. Department of Chemical Engineering University of California, Santa Barbara, CA 93106 Ph: 805-893-7532, Email: [email protected] Web site: http://drugdelivery.engr.ucsb.edu/ Education Ph.D. 1996 Massachusetts Institute of Technology, Chemical Engineering, Cambridge, MA B.S. 1992 University of Bombay (ICT), Chemical Engineering, Mumbai, INDIA Summary of Research Interests and Expertise Prof. Mitragotri has made groundbreaking contributions to the field of drug delivery. His research has advanced fundamental understanding of biological systems and led to the development of new materials as well as technologies for diagnosis and treatment of various ailments including diabetes, cardiovascular diseases, skin diseases and infectious diseases, among others. Many of his technologies have advanced to human clinical studies and are used by people. At the same time, fundamental understanding developed through his research has advanced the understanding of the biology of transport barriers in the human body. His research has made particular impact on the following areas: Transdermal drug delivery: Prof. Mitragotri has established a fundamental knowledge base of transport properties of skin. He also developed mathematical models of skin permeation and analytical tools to study biophysics of skin structure-function relationship (PNAS 2005). Further, he has developed novel technologies to enable transdermal delivery of proteins, peptides and siRNA which otherwise have to be injected using needles. He has pioneered a large number of technologies including low-frequency ultrasound, pulsed microjet injector, high throughput skin experimentation, skin penetrating peptides and ionic liquids for transdermal delivery of proteins, peptides and nucleic acids. Professor Mitragotri’s research has made it possible to painlessly deliver macromolecules using transdermal patches, which was previously considered not feasible.

  • Chemical Engineering Education FACULTY/RESEARCH INTERESTS CHEMICAL and ROBERT G

    I • N • D • E • X GRADUATE EDUCATION ADVERTISEMENTS Akron, Uni versity of.............................. 32 1 Iowa State Uni versity ... .. ... 360 Pensylvani a State Uni versi ty . ... 395 Alabama, University of.... .............. ..... 322 Johns Hopkins Uni versi ty .. .. 361 Pittsburgh. University of 396 Alabama, Huntsville; Uni versity of .............. 323 Kansas, Uni versi ty of .. 362 Polytechnic University .. ...... 397 Alberta, Uni versi ty of... .............. 324 Kansas State University ... 363 Princeton University ... ... 398 Arizona, Uni versity of. ................. .... 325 Kentucky, Uni versity of .... 36-1 Purdue Universit) .. 399 Arizona State Uni versity .... .... 326 Lamar Un iversity ............. 430 Rensselaer Polytechni c Insti tute ........ ... 400 Auburn Uni versity .. ... .... ... .. .... ........ 327 Laval Universite .... 365 Rhode Island. University of 435 Brigham Young Uni versity ......... ..... 427 Lehi gh Uni versity . 366 Rice University .... ........... 40 1 British Columbia, Uni versity of .... 427 Loui siana, Lafayette: Uni versity of .... ..... 367 Rochester, University of.. ..... 402 Brown Uni versity .... ... .... 44 1 Louisiana State University .. 368 Rose Hulman Insti tute of Technology .. ....... 435 Buckne ll Uni versity .. .. ......... 428 Loui siana Tech University ...... 430 Rowan University.................... .... 403 Calgary, Uni versity of . ...... 328 Loui svi ll e, Uni versity of. 431 Rutgers Uni,·ersity .................. .... 404 Cali fo rni a, Berke ley; Un iversity of 329 Manhattan College 369 Saskatchewan. University of .... 436 Cali fo rni a, Davis; Uni versity of ...... 330 Maryland. Uni versi ty of .......... 370 Singapore, National University of .. 405 Cali fo rnia, Irvine; Uni versity of .... ............. 331 Maryland, Baltimore Coun ty: University of 371 South Carolina, University of ....... .. 406 Cali fo rni a, Los Angeles; Uni versit y of .. 332 Massachusetts, Lowell ; Un iversity of .......... 441 South Florida, Unive rsity of .......................
  • Event Program

    Event Program

    BU.EDU/ENG/MATERIALSDAY2019 Boston University Photonics Center September 27, 2019 The Materials Day 2019 feature photo is provided by the Photonics Center. (NANO)MATERIALS FOR BIOSENSING AND DIAGNOSTICS: Novel materials development in fluorescent and plasmonic nanoparticles, anti-fouling surfaces, and textile electronics are helping to propel innovations in personal health, wellness monitoring, and cell phone-based diagnostic tools. Eminent scholars will present on recent advances that are part of a movement to reshape the information each of us has regarding our own health and wellness. HOSTED BY ASSISTANT PROFESSOR ALLISON DENNIS (BME, MSE). AGENDA 8:15 AM REGISTRATION AND CONTINENTAL BREAKFAST 9th Floor East End Lounge 8:45 AM WELCOME | Kenneth Lutchen, Dean, College of Engineering and Gloria Waters, Vice President and Associate Provost for Research 9:00 AM HADI SHAFIEE, BRIGHAM AND WOMEN’S HOSPITAL Mobile Health Diagnostics with Applications in Medicine 9:45 AM ALLISON DENNIS, BOSTON UNIVERSITY Engineering Semiconductor Quantum Dots for Biosensing Applications 10:30 AM MORNING COFFEE BREAK 9th Floor East End Lounge 10:45 AM RUSS ALGAR, UNIVERSITY OF BRITISH COLUMBIA Not Everybody Dyes: Leveraging Quantum Dots and Other Luminescent Nanomaterials for New Opportunities in Bioanalysis 11:30 AM HEATHER CLARK, NORTHEASTERN UNIVERSITY Nanosensors for Chemical Imaging of Acetylcholine in the Brain using MRI 12:15 PM LUNCH BUFFET 9th Floor East End Lounge 12:50 PM LUNCH SPEAKER: SAMIR MITRAGOTRI, HARVARD UNIVERSITY Clinical Translation of
  • Samir Mitragotri, Ph.D

    Samir Mitragotri, Ph.D

    Samir Mitragotri, Ph.D. Department of Chemical Engineering University of California, Santa Barbara, CA 93106 Ph: 805-893-7532, Email: [email protected] Web site: http://drugdelivery.engr.ucsb.edu/ Education Ph.D. 1996 Massachusetts Institute of Technology, Chemical Engineering, Cambridge, MA B.S. 1992 University of Bombay (ICT), Chemical Engineering, Mumbai, INDIA Summary of Research Interests and Expertise Prof. Mitragotri has made groundbreaking contributions to the field of biological barriers and drug delivery. His research has advanced fundamental understanding of biological barriers and has led to the development of new materials as well as technologies for diagnosis and treatment of various ailments including diabetes, cardiovascular diseases, skin diseases and infectious diseases, among others. Many of his technologies have advanced to human clinical studies and products. At the same time, fundamental understanding developed through his research has advanced the understanding of the biology of barriers in the human body. His research has made particular impact on the following areas: Skin and Transdermal drug delivery: Prof. Mitragotri has established a fundamental knowledge base of transport properties of skin. He also developed mathematical models of skin permeation and analytical tools to study biophysics of skin structure-function relationship (PNAS, 2005). Further, he has developed novel technologies to enable transdermal delivery of proteins, peptides and siRNA which otherwise have to be injected using needles. He has pioneered a large number of technologies including low-frequency ultrasound, pulsed microjet injector, high throughput skin experimentation, skin penetrating peptides and ionic liquids for transdermal delivery of proteins, peptides and nucleic acids. Professor Mitragotri’s research has made it possible to painlessly deliver macromolecules using transdermal patches, which was previously considered not feasible.
  • Professor Samir Mitragotri School of Engineering

    Professor Samir Mitragotri School of Engineering

    Professor Samir Mitragotri School of Engineering & Applied Sciences, Harvard University Wyss Institute Email: [email protected] @SMitragotri Positions Held 7/17-present Hiller Professor of Bioengineering, Wyss Professor, Harvard University, 7/17-present Core faculty member, Wyss Institute 01/00-6/17 Department of Chemical Eng., University of California, Santa Barbara Education Ph.D., Chemical Engineering, Massachussetts Institute of Technology, 1996 B.S., Chemical Engineering, Institute of Chemical Technology, Mumbai, 1992 Research Field: Drug Delivery Prof. Mitragotri’s research is focused on drug delivery. His research has developed fundamental understanding of biological barriers of skin, gut, blood brain barrier, and macrophage clearance, and has led to the development of new materials as well as technologies for diagnosis and treatment of various diseases including diabetes, cancer, traumatic brain injury, ARDS and infections, among others. Many of his technologies have advanced to human clinical studies and products. Two of his recent key technological contributions are highlighted below: Macrophage and Red Blood Cell Therapies: Prof. Mitragotri pioneered the field of non-genetic modifications of macrophages and red blood cells (RBCs) through engineered nanoparticles. He demonstrated that nanoparticles attached to red blood cells (cellular hitchhiking) can be delivered to specific organs including lungs, kidney and brain for targeted intervention. He also designed shape- engineered nanoparticles (cellular backpacks) that attach to macrophages and can control their phenotype for various applications including cancer, ARDS and traumatic brain injury. His non-genetic cellular modifications offer an alternative to genome-engineered approaches. Ionic Liquids for Therapeutic Applications: Prof. Mitragotri pioneered the use of designer ionic liquids for drug delivery applications.
  • Handbook| 2021-2022

    Handbook| 2021-2022

    ICT Mumbai Campus ICT Mumbai-IOC Bhubaneswar Campus ICT Marathwada Jalna Campus HANDBOOK | 2021-2022 INSTITUTE OF CHEMICAL TECHNOLOGY Mumbai IOC Bhubaneswar Marathwada Jalna Category I Deemed to be University (MHRD/UGC) Elite Status and Centre of Excellence, Govt. of Maharashtra “National Rank 1 in Atal Innovation Ranking (ARIIA)” by MHRD www.ictmumbai.edu.in VISION • We shall perennially strive to be a vibrant institute with continuously evolving curricula to brighten the future of the chemical, biological, materials and energy industries of the nation, and rank amongst the very best in the world through active participation and scholarship of our faculty, students and alumni. • We shall be creators of sprouting knowledge and design cutting-edge technologies that will have the greatest impact on society and benefit mankind at large. MISSION • We shall generate and sustain an atmosphere conducive to germinating new knowledge at every available opportunity. • The education we shall impart will enable our students to devise new solutions to meet the needs of all segments of society with regard to material and energy, while protecting the environment and conserving the natural resources. • Our endeavors, while extending well beyond the confines of the classroom, will aim to enhance public welfare and our attempts to dissipate knowledge will spread to a greater multi- and cross- disciplinary platform to conduct research, discovery, technology development, service to industry and entrepreneurship, in consonance with India’s aspirations to be a welfare state. We will team scientists and engineers with professionals in other disciplines to arrive at better solutions. • We will provide all our students with a strong foundation to encourage them to be our ambassadors in the professional activities that they choose to undertake in service of society at national and international levels.
  • Samir Mitragotri, Ph.D

    Samir Mitragotri, Ph.D

    Samir Mitragotri, Ph.D. Department of Chemical Engineering University of California, Santa Barbara, CA 93106 Ph: 805-893-7532, Email: [email protected] Web site: http://drugdelivery.engr.ucsb.edu/ Education Ph.D. 1996 Massachusetts Institute of Technology, Chemical Engineering, Cambridge, MA B.S. 1992 University of Bombay (ICT), Chemical Engineering, Mumbai, INDIA Summary of Research Interests and Expertise Prof. Mitragotri has made groundbreaking contributions to the field of drug delivery. His research has advanced fundamental understanding of biological barriers and has led to the development of new materials as well as technologies for diagnosis and treatment of various ailments including diabetes, cardiovascular diseases, skin diseases and infectious diseases, among others. Many of his technologies have advanced to human clinical studies and products. At the same time, fundamental understanding developed through his research has advanced the understanding of the biology of barriers in the human body. His research has made particular impact on the following areas: Skin and Transdermal drug delivery: Prof. Mitragotri has established a fundamental knowledge base of transport properties of skin. He also developed mathematical models of skin permeation and analytical tools to study biophysics of skin structure-function relationship (PNAS 2005). Further, he has developed novel technologies to enable transdermal delivery of proteins, peptides and siRNA which otherwise have to be injected using needles. He has pioneered a large number of technologies including low-frequency ultrasound, pulsed microjet injector, high throughput skin experimentation, skin penetrating peptides and ionic liquids for transdermal delivery of proteins, peptides and nucleic acids. Professor Mitragotri’s research has made it possible to painlessly deliver macromolecules using transdermal patches, which was previously considered not feasible.